0.61
price down icon18.67%   -0.14
after-market Handel nachbörslich: .63 0.02 +3.28%
loading

AEON Biopharma Inc. Aktie (AEON) Neueste Nachrichten

pulisher
02:35 AM

Cervical Dystonia Market Expected to Experience Major Growth - openPR

02:35 AM
pulisher
Mar 02, 2025

AIM ImmunoTech, PepGen, Aeon, Tiziana, Moleculin: 5 Biotech Stocks That Led Retail Message Growth Last Week - Asianet Newsable

Mar 02, 2025
pulisher
Feb 27, 2025

AEON Biopharma, Inc. Deloitte, Inc. Announces Update of Phase 2 Double Blind Study of ABP-450 in the Treatment of Migraine - Marketscreener.com

Feb 27, 2025
pulisher
Feb 27, 2025

AEON Biopharma Announces Preliminary Top-Line Results from Phase 2 Interim Analysis of ABP-450 in the Preventive Treatment of Chronic Migraine - Marketscreener.com

Feb 27, 2025
pulisher
Feb 27, 2025

AEON Biopharma, Inc. Announces Executive Changes -May 16, 2024 at 04:28 pm EDT - Marketscreener.com

Feb 27, 2025
pulisher
Feb 27, 2025

AEON Biopharma, Inc. Announces Strategic Reprioritization to Pursue A Biosimilar Pathway for ABP-450 - Marketscreener.com

Feb 27, 2025
pulisher
Feb 27, 2025

AEON Biopharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 - Marketscreener.com

Feb 27, 2025
pulisher
Feb 26, 2025

Stock market news: AEON Biopharma plummented by 65.33% while Enveric Biosciences skyrocketed by 90.68% during midday trading - Business Upturn

Feb 26, 2025
pulisher
Feb 26, 2025

Stock market today: AEON Biopharma plunged by 63.17% while Enveric Biosciences surged by 124.66% in early trading - Business Upturn

Feb 26, 2025
pulisher
Feb 25, 2025

AEON Biopharma To Implement 1-for-72 Reverse Stock Split For Compliance With NYSE Rules - Nasdaq

Feb 25, 2025
pulisher
Feb 24, 2025

AEON Biopharma executes reverse stock split to comply with NYSE standards - Investing.com Australia

Feb 24, 2025
pulisher
Feb 24, 2025

Aeon Biopharma Approves 1-For-72 Reverse Stock Split -February 24, 2025 at 02:53 pm EST - Marketscreener.com

Feb 24, 2025
pulisher
Feb 24, 2025

AEON Biopharma shares plunge as it announces reverse stock split - MSN

Feb 24, 2025
pulisher
Feb 24, 2025

AEON Biopharma Stockholders Approve Key Proposals - TipRanks

Feb 24, 2025
pulisher
Feb 24, 2025

AEON Biopharma, Inc. Announces Reverse Stock Split - The Manila Times

Feb 24, 2025
pulisher
Feb 24, 2025

AEON Biopharma Announces 1-for-72 Reverse Stock Split Effective February 26, 2025 - Nasdaq

Feb 24, 2025
pulisher
Feb 24, 2025

Can AEON's 1-for-72 Reverse Split Save Its NYSE Listing Status? - StockTitan

Feb 24, 2025
pulisher
Feb 10, 2025

AEON Biopharma Inc (AEON) Shares Down Despite Recent Market Volatility - The News Heater

Feb 10, 2025
pulisher
Feb 10, 2025

Watch this stock’s price performance: AEON Biopharma Inc (AMEX:AEON) - US Post News

Feb 10, 2025
pulisher
Feb 10, 2025

AEON Biopharma Receives Notice Of Non-Compliance With NYSE American Listing Standards - Nasdaq

Feb 10, 2025
pulisher
Feb 10, 2025

AEON Biopharma Inc (AMEX: AEON) Could See A Rise In Prices Shortly. - Marketing Sentinel

Feb 10, 2025
pulisher
Feb 10, 2025

Investor’s Delight: AEON Biopharma Inc (AEON) Closes Weak at 0.13, Down -6.93 - The Dwinnex

Feb 10, 2025
pulisher
Feb 09, 2025

AEON Biopharma receives NYSE non-compliance notice - MSN

Feb 09, 2025
pulisher
Feb 08, 2025

AEON Biopharma, Inc. Receives Notice of Non-Compliance with NYSE American Continued Listing Standards - The Manila Times

Feb 08, 2025
pulisher
Feb 07, 2025

Aeon Biopharma Gets NYSE American Noncompliance Notice -February 07, 2025 at 05:06 pm EST - Marketscreener.com

Feb 07, 2025
pulisher
Feb 07, 2025

Aeon Biopharma Receives Notice Of Non-Compliance With NYSE American Continued Listing Standards - Marketscreener.com

Feb 07, 2025
pulisher
Feb 07, 2025

AEON Biopharma Inc [AEON] Stock trading around $0.14 per share: What’s Next? - The DBT News

Feb 07, 2025
pulisher
Feb 07, 2025

AEON Biopharma, Inc. Receives Notice of Non-Compliance from NYSE American Due to Stockholders' Deficit - Nasdaq

Feb 07, 2025
pulisher
Feb 05, 2025

AEON Biopharma Inc Inc. (AEON) Price Performance: A Comparative Analysis with Competitors - The InvestChronicle

Feb 05, 2025
pulisher
Feb 05, 2025

Is AEON Biopharma Inc (AMEX: AEON) Still Trending? - Stocks Register

Feb 05, 2025
pulisher
Feb 04, 2025

Take off with AEON Biopharma Inc (AEON): Get ready for trading - SETE News

Feb 04, 2025
pulisher
Feb 03, 2025

Analyzing AEON’s current quarter earnings projections - US Post News

Feb 03, 2025
pulisher
Jan 31, 2025

Retail Traders Flocked To These 5 Biotech Stocks In January — Here’s Why - Asianet Newsable

Jan 31, 2025
pulisher
Jan 27, 2025

AEON Biopharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 - Marketscreener.com

Jan 27, 2025
pulisher
Jan 24, 2025

Midday Stock Roundup: FivePoint Holdings Jumps 36% - Orange County Business Journal

Jan 24, 2025
pulisher
Jan 21, 2025

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Jan 21, 2025
pulisher
Jan 21, 2025

Kairos, OS Therapies, AEON See Highest Weekly Spike In Retail Following Among Biotechs: Here's Why - NewsBreak

Jan 21, 2025
pulisher
Jan 20, 2025

Irvine-based Aeon Biopharma Raises $20 Million - Orange County Business Journal

Jan 20, 2025
pulisher
Jan 17, 2025

12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga

Jan 17, 2025
pulisher
Jan 17, 2025

Dow Jumps Over 300 Points; US Industrial Production Beats Estimates - Benzinga

Jan 17, 2025
pulisher
Jan 16, 2025

Why Taiwan Semiconductor Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket - Benzinga

Jan 16, 2025
pulisher
Jan 15, 2025

AEON Biopharma Inc (AMEX: AEON) -9.93% Decline Turns Investors Away - Stocks Register

Jan 15, 2025
pulisher
Jan 15, 2025

AEON Biopharma (NASDAQ:AEON) Stock Price Down 9.9% – What’s Next? - Defense World

Jan 15, 2025
pulisher
Jan 13, 2025

12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga

Jan 13, 2025
pulisher
Jan 13, 2025

AEON Stock Plummets to 52-Week Low at $0.16 Amid Market Turbulence - Investing.com

Jan 13, 2025
pulisher
Jan 10, 2025

AEON’s Value Tanks As It Closes $20m Offering Amid Botox Biosimilar Aspirations - News & Insights

Jan 10, 2025
pulisher
Jan 08, 2025

AEON Biopharma announces share offering - MSN

Jan 08, 2025
pulisher
Jan 07, 2025

AEON Biopharma, Inc. Announces Closing of $20.0 Million Underwritten Public Offering - The Manila Times

Jan 07, 2025
pulisher
Jan 07, 2025

AEON Biopharma, Inc. Announces Closing of $20.0 Million Underwritten Public Offering - Benzinga

Jan 07, 2025
pulisher
Jan 07, 2025

AEON Biopharma Raises $20M in Public Offering with Dual-Warrant Structure - StockTitan

Jan 07, 2025
pulisher
Jan 07, 2025

Form 424B5 AEON Biopharma, Inc. - StreetInsider.com

Jan 07, 2025
pulisher
Jan 06, 2025

AEON Biopharma sets $20 million public offering pricing By Investing.com - Investing.com Nigeria

Jan 06, 2025
$310.03
price down icon 3.13%
$19.13
price down icon 7.54%
$22.96
price up icon 1.23%
$33.86
price up icon 0.65%
biotechnology ONC
$245.53
price down icon 9.67%
$111.56
price down icon 1.20%
Kapitalisierung:     |  Volumen (24h):